Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -22.61%14.88M | 85.21%14.37M | 268.13%17.47M | 37.70%52.69M | 142.10%20.95M | 249.43%19.23M | -41.68%7.76M | -56.08%4.75M | -56.66%38.26M | -32.72%8.66M |
| Cost of revenue | -7.83%14.52M | 175.94%14M | 369.11%14.93M | 53.48%42.64M | 286.80%18.61M | 236.41%15.75M | -50.43%5.07M | -60.48%3.18M | -62.83%27.78M | -50.06%4.81M |
| Gross profit | -89.58%362K | -86.36%366K | 62.57%2.54M | -4.13%10.05M | -38.91%2.35M | 323.78%3.48M | -12.41%2.68M | -43.20%1.56M | -22.60%10.48M | 18.88%3.85M |
| Operating expense | 1.01%2.79M | 47.74%2.49M | 57.07%2.1M | -0.33%8.34M | -0.97%2.56M | 59.71%2.76M | -20.53%1.68M | -31.01%1.34M | -43.24%8.37M | -65.56%2.58M |
| Selling and administrative expenses | 45.87%2.53M | 14.91%1.96M | 16.70%1.76M | -5.31%7.19M | -5.50%2.27M | 4.52%1.73M | -1.79%1.7M | -16.26%1.51M | -22.97%7.6M | -15.51%2.4M |
| -Selling and marketing expense | 23.68%235K | 14.96%146K | 73.87%193K | -0.60%610.82K | 52.50%183K | 26.67%190K | -27.43%127K | -34.32%111K | -59.63%614.49K | -66.13%120K |
| -General and administrative expense | 48.61%2.29M | 14.90%1.81M | 12.16%1.57M | -5.72%6.58M | -8.55%2.09M | 2.32%1.54M | 1.09%1.58M | -14.39%1.4M | -16.28%6.98M | -8.30%2.28M |
| Other operating expenses | -51.69%501K | 133.76%734K | 88.13%523K | 33.84%2.16M | 294.91%1.09M | 229.21%1.04M | -47.40%314K | -34.28%278K | -76.12%1.61M | -94.86%275K |
| Total other operating income | 3,300.00%238K | -38.92%204K | -59.11%184K | 20.19%1.01M | 741.05%799K | -97.12%7K | 56.81%334K | 56.79%450K | -54.98%838.26K | -86.35%95K |
| Operating profit | -441.15%-2.43M | -312.41%-2.12M | 95.13%441K | -19.18%1.71M | -116.47%-208K | 178.24%712K | 5.83%999K | -72.24%226K | 275.27%2.11M | 129.63%1.26M |
| Net non-operating interest income (expenses) | -178.87%-198K | -101.20%-167K | -81.33%-136K | -118.85%-320.15K | -56.90%-91K | -77.50%-71K | -730.00%-83K | -97.37%-75K | -49.78%-146.29K | 42.38%-58K |
| Non-operating interest income | -30.00%7K | -40.00%6K | -11.11%8K | -59.82%37.69K | -18.18%9K | -33.33%10K | -54.55%10K | -80.43%9K | -26.21%93.81K | 8.65%11K |
| Non-operating interest expense | 153.09%205K | 86.02%173K | 71.43%144K | 47.31%353.72K | 44.93%100K | 47.27%81K | 190.63%93K | 0.00%84K | 5.30%240.11K | -39.49%69K |
| Total other finance cost | ---- | ---- | ---- | 24,376.47%4.13K | ---- | ---- | ---- | ---- | 99.48%-17 | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 56.81%334K | |||||||||
| Income before tax | -509.83%-2.63M | -349.89%-2.29M | 101.99%305K | -29.46%1.39M | -124.81%-299K | 167.47%641K | -1.93%916K | -80.54%151K | 250.89%1.96M | 127.62%1.21M |
| Income tax | -61.45%-289K | -50.00%-114K | -8.33%77K | -95.42%72.73K | 412.82%244K | -358.97%-179K | -105.11%-76K | -61.29%84K | -42.32%1.59M | 94.96%-78K |
| Net income | -385.12%-2.34M | -319.25%-2.18M | 240.30%228K | 248.50%1.31M | -142.32%-543K | 190.01%820K | 279.06%992K | -88.01%67K | 109.29%376.82K | 145.58%1.28M |
| Net income continuous operations | -385.12%-2.34M | -319.25%-2.18M | 240.30%228K | 248.50%1.31M | -142.32%-543K | 190.01%820K | 279.06%992K | -88.01%67K | 109.29%376.82K | 145.58%1.28M |
| Noncontrolling interests | 76.47%-8K | -18.67%-178K | 90.00%19K | 59.84%-213.79K | 75.22%-28K | 60.92%-34K | 5.06%-150K | 105.75%10K | -70.50%-532.35K | 74.10%-113K |
| Net income attributable to the company | -372.83%-2.33M | -274.87%-2M | 266.67%209K | 67.96%1.53M | -136.89%-515K | 203.64%854K | 388.38%1.14M | -92.22%57K | 124.29%909.17K | 158.69%1.4M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -372.83%-2.33M | -274.87%-2M | 266.67%209K | 67.96%1.53M | -136.89%-515K | 203.64%854K | 388.38%1.14M | -92.22%57K | 124.29%909.17K | 158.69%1.4M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -378.57%-0.0078 | -276.32%-0.0067 | 250.00%0.0007 | 59.38%0.0051 | -134.69%-0.0017 | 196.55%0.0028 | 371.43%0.0038 | -92.31%0.0002 | 124.24%0.0032 | 158.33%0.0049 |
| Diluted earnings per share | -378.57%-0.0078 | -276.32%-0.0067 | 250.00%0.0007 | 59.38%0.0051 | -134.69%-0.0017 | 196.55%0.0028 | 371.43%0.0038 | -92.31%0.0002 | 124.24%0.0032 | 158.33%0.0049 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.